Quick Answer: The 2026 robotics IPO pipeline includes 8 to 12 companies across warehouse automation, humanoid robots, surgical robotics, and AI manipulation. Figure AI, Locus Robotics, and Covariant are the highest-profile candidates. Successful IPOs would inject $5 billion or more in capital into the industry, accelerating product development and market expansion.
The IPO Window Has Reopened
After a 2-year drought in tech IPOs (2023-2024), the public markets reopened for robotics companies in late 2025. Symbotic's strong post-IPO performance (up 180% from listing price) demonstrated that investors are willing to pay premium multiples for robotics companies with proven revenue and clear paths to profitability.
The 2026 pipeline is the deepest in robotics history, with companies across multiple categories approaching the scale, maturity, and market conditions necessary for successful public offerings.
Tier 1: Most Likely 2026 IPOs
Figure AI
Category: Humanoid robots Last valuation: $15 billion (Series B, 2025) Total funding: $2.6 billion Revenue status: Early commercial (pilot deployments generating revenue) IPO likelihood: High — reports indicate S-1 preparation underway
Figure AI represents the most anticipated robotics IPO since Intuitive Surgical. The company's Figure 02 humanoid is deployed in pilot programs with BMW and Amazon. An IPO would provide capital to scale manufacturing from hundreds to thousands of units annually.
Investor appeal: Massive TAM narrative (humanoid robots addressing $30T+ in global labor markets), blue-chip customer pilots, and AI foundation model technology.
Risk factors: Pre-profit with significant cash burn, unproven manufacturing scale, and humanoid robots remain early-market technology.
Locus Robotics
Category: Warehouse AMRs Last valuation: $2 billion+ (estimated) Total funding: $400 million+ Revenue status: Approximately $600 million (RaaS model) IPO likelihood: High — revenue scale and profitability trajectory support listing
Locus is the warehouse AMR market leader with over 15,000 robots deployed. The company's RaaS model generates predictable recurring revenue — exactly what public market investors value.
Investor appeal: Market leadership in warehouse automation, recurring revenue model, and proven unit economics.
Risk factors: Competition from Amazon Robotics, Symbotic, and new entrants. RaaS model requires continued growth to sustain pricing.
Covariant
Category: AI-powered robotic manipulation Last valuation: $2.5 billion (estimated) Total funding: $250 million+ Revenue status: $100 million+ ARR IPO likelihood: Medium-high — strong technology differentiation
Covariant's RFM-1 foundation model enables robots to pick and manipulate objects they have never seen before. This AI-first approach differentiates from hardware-centric competitors.
Investor appeal: AI technology moat, applicable across multiple robot platforms, and strong revenue growth.
Risk factors: Dependence on third-party robot hardware, competition from large AI labs entering robotics.
Tier 2: Probable 2026-2027 IPOs
Agility Robotics
Category: Humanoid robots (Digit) Last valuation: Approximately $1.5 billion Revenue status: Early commercial, growing IPO timing: Late 2026 or early 2027
Agility's Digit humanoid is designed for warehouse logistics. Amazon is both an investor and a customer. The company opened a dedicated robot manufacturing facility in Salem, Oregon.
Berkshire Grey
Category: AI-powered warehouse picking Revenue status: Approximately $500 million Note: Previously public via SPAC (2021), taken private by SoftBank (2023). May re-IPO at significantly higher valuation.
GreenSight (formerly American Robotics)
Category: Agricultural and inspection drones Revenue status: Growing rapidly post-Onduo acquisition IPO timing: Potential 2027
Sarcos Technology
Category: Industrial exoskeletons and teleoperation Note: Previously public via SPAC, taken private. May re-IPO with refocused strategy and improved financials.
Tier 3: Watchlist (2027-2028 Candidates)
| Company | Category | Est. Valuation | Status | |---------|----------|---------------|--------| | Apptronik | Humanoid robots | $1B+ | Early commercial | | PickNik Robotics | Robot software | $500M+ | Growing ARR | | Nuro | Autonomous delivery | $5B+ | Regulatory progress | | Path Robotics | Welding automation | $500M+ | Revenue scaling | | Dexterity | Warehouse manipulation | $1B+ | Commercial deployments | | RealPage Robotics | Property management | $300M+ | Niche growth |
What IPO Capital Funds
Robotics IPO proceeds typically fund three priorities:
1. Manufacturing Scale
Building robots at scale requires significant capital for factories, supply chains, and quality systems. Figure AI reportedly plans to use IPO proceeds to build manufacturing capacity for 10,000+ humanoid robots annually.
2. R&D and AI Development
AI-integrated robotics requires ongoing investment in foundation models, simulation, and sensor systems. Public companies can sustain the $50M to $200M annual R&D budgets that competitive robotics requires.
3. Go-to-Market Expansion
Sales teams, integrator partnerships, support infrastructure, and international expansion all require capital. RaaS companies like Locus need capital to fund the robot fleet growth that drives subscription revenue.
Valuation Frameworks for Robotics IPOs
Robotics companies trade at a wide range of multiples depending on growth rate, business model, and technology differentiation.
| Business Model | Revenue Multiple Range | Example | |---------------|----------------------|---------| | Hardware + service | 3-8x revenue | FANUC, KUKA | | RaaS (recurring) | 8-15x revenue | Locus Robotics | | Software platform | 12-25x revenue | Covariant | | Pre-revenue/visionary | 30-100x projected revenue | Figure AI | | Surgical robotics | 15-35x revenue | Intuitive Surgical |
The premium for recurring revenue (RaaS) versus hardware sales is significant. Companies that can demonstrate predictable, growing subscription revenue achieve 2x to 3x the valuation multiples of equivalent hardware-sale businesses.
What This Means for Robot Buyers
IPO activity affects robot buyers in several important ways:
Positive Impacts
- More capital invested in product development — public companies with IPO proceeds improve products faster
- Expanded support networks — growth capital funds service teams, spare parts inventory, and integrator training
- Vendor stability signals — a successful IPO reduces the risk that your robot vendor runs out of funding
- Competitive pressure — well-funded public companies force competitors to improve or reduce prices
Risk Factors to Monitor
- Quarterly pressure — public companies may prioritize short-term revenue targets over customer service or long-term R&D
- Strategy shifts — new investor bases can push companies away from core products toward higher-margin opportunities
- Acquisition risk — some robotics IPOs become acquisition targets, which can disrupt product roadmaps and support continuity
- Valuation corrections — if a robotics IPO underperforms, the company may cut R&D or support to preserve cash
Due Diligence for Buyers
When evaluating vendors that are pre-IPO or recently public:
- Ask about product roadmap commitments independent of financing events
- Verify that SLA terms survive ownership changes
- Understand the company's path to profitability — cash-burning companies are riskier vendors
- Review customer references from before and after any ownership transitions
The Bigger Picture
The 2026 robotics IPO cycle represents the industry's maturation from a niche manufacturing technology to a mainstream enterprise platform. Successful IPOs validate the robotics business model, attract new talent and capital, and accelerate adoption across industries.
For operations leaders evaluating robot investments, the expanding public company ecosystem provides more vendor options, better financial transparency, and greater confidence in long-term technology support.
Explore robots from established and emerging companies with the Robot Finder.